$2.29
Insights on Medavail Holdings Inc
Revenue is down for the last 4 quarters, 11.46M → 405.0K (in $), with an average decrease of 32.5% per quarter
Netprofit is up for the last 4 quarters, -12.12M → -5.79M (in $), with an average increase of 33.6% per quarter
In the last 1 year, Medavail Holdings Inc has experienced a drawdown of -87.9%, however High Tide Inc resisted the overall trend and outperformed by 85.2%
3.05%
Downside
Day's Volatility :17.77%
Upside
15.19%
16.59%
Downside
52 Weeks Volatility :94.32%
Upside
93.19%
Period | Medavail Holdings Inc | Sector (Consumer Staples) | Index (Russel 2000) |
---|---|---|---|
3 Months | -71.17% | -1.3% | 0.0% |
6 Months | -87.71% | -3.4% | 0.0% |
1 Year | -87.86% | -7.0% | -2.4% |
3 Years | -99.62% | 4.2% | -6.5% |
Market Capitalization | 4.2M |
Book Value | $14.28 |
Dividend Share | 0.0 |
Dividend Yield | 0.0% |
Earnings Per Share (EPS) | -35.56 |
Wall Street Target Price | 4.0 |
Profit Margin | -106.17% |
Operating Margin TTM | -1099.75% |
Return On Assets TTM | -68.15% |
Return On Equity TTM | -194.67% |
Revenue TTM | 43.3M |
Revenue Per Share TTM | 26.19 |
Quarterly Revenue Growth YOY | -25.4% |
Gross Profit TTM | 2.2M |
EBITDA | -40.5M |
Diluted Eps TTM | -35.56 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 74.67%
FY17 | Y/Y Change | |
---|---|---|
Revenue | 526.0K | ↑ 60.86% |
Net Income | -4.1M | ↓ 6.52% |
Net Profit Margin | -771.48% | ↑ 556.04% |
FY18 | Y/Y Change | |
---|---|---|
Revenue | 360.0K | ↓ 31.56% |
Net Income | -3.2M | ↓ 20.58% |
Net Profit Margin | -895.28% | ↓ 123.8% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 3.8M | ↑ 947.5% |
Net Income | -22.3M | ↑ 590.88% |
Net Profit Margin | -590.48% | ↑ 304.8% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 14.0M | ↑ 270.41% |
Net Income | -26.1M | ↑ 17.38% |
Net Profit Margin | -187.11% | ↑ 403.37% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 22.1M | ↑ 58.43% |
Net Income | -43.8M | ↑ 67.64% |
Net Profit Margin | -198.0% | ↓ 10.89% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 43.1M | ↑ 94.81% |
Net Income | -47.6M | ↑ 8.68% |
Net Profit Margin | -110.45% | ↑ 87.55% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Revenue | 9.1M | ↑ 25.19% |
Net Income | -13.3M | ↑ 5.14% |
Net Profit Margin | -145.66% | ↑ 27.77% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Revenue | 11.2M | ↑ 22.71% |
Net Income | -11.7M | ↓ 11.73% |
Net Profit Margin | -104.77% | ↑ 40.89% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 11.5M | ↑ 2.48% |
Net Income | -12.1M | ↑ 3.44% |
Net Profit Margin | -105.76% | ↓ 0.99% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 11.4M | ↓ 0.97% |
Net Income | -11.1M | ↓ 8.67% |
Net Profit Margin | -97.53% | ↑ 8.23% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 11.4M | ↑ 0.0% |
Net Income | -11.1M | ↓ 0.01% |
Net Profit Margin | -97.52% | ↑ 0.01% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 405.0K | ↓ 96.43% |
Net Income | -5.8M | ↓ 47.68% |
Net Profit Margin | -1.4K% | ↓ 1332.36% |
FY17 | Y/Y Change | |
---|---|---|
Total Assets | 4.8M | ↓ 19.56% |
Total Liabilities | 431.0K | ↓ 32.97% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 4.5M | ↓ 7.09% |
Total Liabilities | 1.6M | ↑ 279.12% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 18.0M | ↑ 304.11% |
Total Liabilities | 114.6M | ↑ 6916.4% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 69.3M | ↑ 285.11% |
Total Liabilities | 8.3M | ↓ 92.79% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 38.1M | ↓ 44.98% |
Total Liabilities | 19.1M | ↑ 130.76% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 33.1M | ↓ 13.14% |
Total Liabilities | 12.3M | ↓ 35.46% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 27.7M | ↓ 27.4% |
Total Liabilities | 21.1M | ↑ 10.52% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 52.8M | ↑ 90.79% |
Total Liabilities | 20.0M | ↓ 4.89% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 49.9M | ↓ 5.64% |
Total Liabilities | 18.5M | ↓ 7.49% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 33.1M | ↓ 33.54% |
Total Liabilities | 12.3M | ↓ 33.63% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 33.1M | ↑ 0.0% |
Total Liabilities | 12.3M | ↑ 0.0% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 29.9M | ↓ 9.73% |
Total Liabilities | 6.9M | ↓ 44.24% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -3.3M | ↓ 14.09% |
Investing Cash Flow | -1.0M | - |
Financing Cash Flow | 2.3M | ↓ 17.59% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -19.5M | ↑ 501.42% |
Investing Cash Flow | -402.0K | ↓ 61.35% |
Financing Cash Flow | 25.0M | ↑ 966.87% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -28.6M | ↑ 46.5% |
Investing Cash Flow | -817.0K | ↑ 103.23% |
Financing Cash Flow | 78.6M | ↑ 214.57% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -42.5M | ↑ 48.49% |
Investing Cash Flow | -3.3M | ↑ 305.63% |
Financing Cash Flow | 7.9M | ↓ 89.92% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -47.7M | ↑ 12.1% |
Investing Cash Flow | -2.3M | ↓ 31.38% |
Financing Cash Flow | 42.0M | ↑ 429.51% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -13.3M | ↓ 7.54% |
Investing Cash Flow | -852.0K | ↓ 18.47% |
Financing Cash Flow | -23.0K | ↓ 97.11% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -12.5M | ↓ 6.14% |
Investing Cash Flow | -874.0K | ↑ 2.58% |
Financing Cash Flow | 37.3M | ↓ 162065.22% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -11.6M | ↓ 7.08% |
Investing Cash Flow | -171.0K | ↓ 80.43% |
Financing Cash Flow | 9.7M | ↓ 73.87% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -10.4M | ↓ 10.27% |
Investing Cash Flow | -377.0K | ↑ 120.47% |
Financing Cash Flow | -5.0M | ↓ 151.3% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -10.4M | ↑ 0.0% |
Investing Cash Flow | -41.0K | ↓ 89.12% |
Financing Cash Flow | -5.0M | ↑ 0.0% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -4.4M | ↓ 57.82% |
Investing Cash Flow | -41.0K | ↑ 0.0% |
Financing Cash Flow | -17.0K | ↓ 99.66% |
Sell
Neutral
Buy
Medavail Holdings Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Medavail Holdings Inc | -35.86% | -87.71% | -87.86% | -99.62% | 100.85% |
![]() Petmed Express Inc | 8.59% | -49.61% | -59.8% | -73.38% | -67.29% |
![]() Walgreens Boots Alliance, Inc. | -5.79% | -34.95% | -49.47% | -51.66% | -75.27% |
![]() 111 Inc | -25.53% | -33.96% | -37.5% | -73.04% | -78.07% |
![]() High Tide Inc | 10.69% | 27.38% | -2.73% | -82.17% | -82.17% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Medavail Holdings Inc | NA | NA | NA | 0.0 | -1.95 | -0.68 | 0.0 | 14.28 |
![]() Petmed Express Inc | 1191.0 | NA | 2.58 | 0.4 | -0.05 | -0.03 | 0.13 | 5.57 |
![]() Walgreens Boots Alliance, Inc. | 7.19 | NA | 6.16 | 3.99 | -0.12 | 0.01 | 0.09 | 23.18 |
![]() 111 Inc | NA | NA | NA | 0.0 | -0.51 | -0.05 | 0.0 | -6.07 |
![]() High Tide Inc | NA | NA | NA | -0.12 | -0.34 | -0.02 | 0.0 | 2.12 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Medavail Holdings Inc | Buy | $4.2M | 100.85% | NA | -106.17% |
![]() Petmed Express Inc | Sell | $162.6M | -67.29% | 1191.0 | -2.25% |
![]() Walgreens Boots Alliance, Inc. | Hold | $17.9B | -75.27% | 7.19 | -2.21% |
![]() 111 Inc | Buy | $158.7M | -78.07% | NA | -1.98% |
![]() High Tide Inc | Buy | $120.9M | -82.17% | NA | -13.34% |
Redmile Group, LLC
Ally Bridge Group (NY) LLC
Alyeska Investment Group, L.P.
PURA VIDA INVESTMENTS, LLC
Cigna Investments Inc
Vanguard Group Inc
Medavail Holdings Inc’s price-to-earnings ratio stands at None
Read Moremedavail inc. is the developer of the medcenter automated dispensing and medication management technologies. the company designs and manufactures pharmacist-controlled automated prescription medicine dispensing vaults, similar in appearance to atms. intended for deployment in hospitals, pharmacies, medical clinics, and other locations. the company integrates advanced robotics, two-way video teleconferencing, and a secure network for patients medical information to create a prescription medication dispensing system.
Organization | Medavail Holdings Inc |
Employees | 279 |
CEO | Ms. Ramona Seabaugh |
Industry | Technology Services |
Asymmetric Smart Alpha S&p 500 Etf
$2.29
-3.38%
Advisorshares Alpha Dna Equity Sentiment Etf
$2.29
-3.38%
Falcon's Beyond Global Inc
$2.29
-3.38%
Jaguar Global Growth Corporation I
$2.29
-3.38%
Missfresh Ltd
$2.29
-3.38%
Shuaa Partners Acquisition Corp I
$2.29
-3.38%
Rose Hill Acquisition Corp
$2.29
-3.38%
Partners Bancorp
$2.29
-3.38%
Mercantile Bank Corp
$2.29
-3.38%